Medpace Research, Inc.
(Other OTC/NBB : NRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Distribution Services » Medical Distributors
symbolcompany%chnglast%shortavg$volume
MCKMcKesson Corp. -0.38%321.162.9%$391.47m
ABCAmerisourceBergen Corp. 0.12%140.888.0%$193.37m
CAHCardinal Health, Inc. -0.02%52.242.8%$114.34m
HSICHenry Schein, Inc. -0.63%75.671.7%$68.34m
HLFHerbalife Nutrition Ltd. 0.70%21.5925.2%$38.64m
PDCOPatterson Cos., Inc. -1.83%29.5411.5%$30.28m
OMIOwens & Minor, Inc. -1.35%32.2112.5%$22.63m
YI111, Inc. 2.18%2.340.0%$1.06m
COSMCosmos Holdings, Inc. 9.22%0.420.0%$0.89m
MOHOECMOHO Ltd. 4.33%0.190.0%$0.23m
MYOMyomo, Inc. 1.47%1.730.0%$0.19m
JWELJowell Global Ltd. 5.31%2.580.0%$0.15m

Company Profile

NephroGenex is a drug-development company focusing on kidney disease. The Company is developing Pyridorinâ„¢ (pyridoxamine dihydrochloride) as a treatment to slow the progression of diabetic kidney disease.